HK1130799A1 - Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication - Google Patents
Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationInfo
- Publication number
- HK1130799A1 HK1130799A1 HK09109448.0A HK09109448A HK1130799A1 HK 1130799 A1 HK1130799 A1 HK 1130799A1 HK 09109448 A HK09109448 A HK 09109448A HK 1130799 A1 HK1130799 A1 HK 1130799A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- respiratory syncytial
- syncytial virus
- virus replication
- containing benzimidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104810 | 2003-12-18 | ||
| US56718204P | 2004-04-30 | 2004-04-30 | |
| EP04105312 | 2004-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1130799A1 true HK1130799A1 (en) | 2010-01-08 |
Family
ID=34704695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09109448.0A HK1130799A1 (en) | 2003-12-18 | 2009-10-13 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7449463B2 (ru) |
| EP (1) | EP1697345B1 (ru) |
| JP (1) | JP4951348B2 (ru) |
| KR (1) | KR100967406B1 (ru) |
| CN (2) | CN1894237A (ru) |
| AP (1) | AP2150A (ru) |
| AR (1) | AR046959A1 (ru) |
| AT (1) | ATE388950T1 (ru) |
| AU (1) | AU2004298460B2 (ru) |
| BR (1) | BRPI0417268B8 (ru) |
| CA (1) | CA2548668C (ru) |
| CY (1) | CY1108142T1 (ru) |
| DE (1) | DE602004012448T2 (ru) |
| DK (1) | DK1697345T3 (ru) |
| EA (1) | EA009876B1 (ru) |
| EG (1) | EG25799A (ru) |
| ES (1) | ES2303653T3 (ru) |
| HK (1) | HK1130799A1 (ru) |
| HR (1) | HRP20080245T3 (ru) |
| IL (1) | IL175910A (ru) |
| ME (1) | ME01042B (ru) |
| MX (1) | MXPA06007112A (ru) |
| MY (1) | MY143573A (ru) |
| NO (1) | NO339314B1 (ru) |
| NZ (1) | NZ547479A (ru) |
| PL (1) | PL1697345T3 (ru) |
| PT (1) | PT1697345E (ru) |
| RS (1) | RS50584B (ru) |
| SI (1) | SI1697345T1 (ru) |
| TW (1) | TWI351401B (ru) |
| UA (1) | UA84718C2 (ru) |
| WO (1) | WO2005058871A1 (ru) |
| ZA (1) | ZA200605894B (ru) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| TWI370820B (en) | 2005-04-27 | 2012-08-21 | Takeda Pharmaceutical | Fused heterocyclic compounds |
| RU2434000C2 (ru) * | 2005-06-20 | 2011-11-20 | Тиботек Фармасьютикалз Лтд. | 1-(2-амино-3-(замещенный алкил)-3н-бензимидазоилметил)-3-замещенные-1,3-дигидробензоимидазол-2-оны с активностью в отношении респираторно-синцитиального вируса |
| US8178694B2 (en) | 2005-06-20 | 2012-05-15 | Tibotec Pharmaceuticals Ltd. | Heterocyclylaminoalkyl substituted benzimidazoles |
| US20120148678A1 (en) | 2010-12-08 | 2012-06-14 | Advanced Technologies And Regenerative Medicine, Llc. | Sustained release of poorly water soluble active compounds |
| TWI650321B (zh) | 2011-10-14 | 2019-02-11 | 美商安比特生物科學公司 | 雜環化合物及其使用方法 |
| UA119050C2 (uk) * | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| JO3637B1 (ar) * | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
| CN109562160B (zh) * | 2016-05-10 | 2022-07-29 | 乔治亚州立大学研究基金会股份有限公司 | 用于治疗rsv的双环稠合的吡唑衍生物 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| KR102296703B1 (ko) | 2017-03-20 | 2021-09-01 | 포르마 세라퓨틱스 인크. | 피루베이트 키나제 (pkr) 활성화제로서의 피롤로피롤 조성물 |
| TW201932470A (zh) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 具有抗ｒｓｖ活性之吡唑并嘧啶 |
| KR20200116099A (ko) | 2018-01-31 | 2020-10-08 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Rsv에 대한 활성을 갖는 시클로알킬 치환 피라졸로피리미딘 |
| MA52348A (fr) | 2018-04-23 | 2021-03-03 | Janssen Sciences Ireland Unlimited Co | Composés hétéroaromatiques ayant une activité contre vrs |
| US20230055923A1 (en) | 2018-09-19 | 2023-02-23 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
| GB201820751D0 (en) * | 2018-12-19 | 2019-01-30 | Bp Oil Int | Methods for preparing intermediates |
| US20220289763A1 (en) | 2019-07-22 | 2022-09-15 | Lupin Limited | Macrocyclic Compounds as Sting Agonists and Methods and Uses Thereof |
| JP7329239B2 (ja) | 2019-09-20 | 2023-08-18 | 株式会社タマディック | フライトシミュレーター |
| EP4384168A1 (en) * | 2021-08-13 | 2024-06-19 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2376785A1 (en) * | 1999-06-28 | 2001-01-04 | Janssen Pharmaceutica N.V. | Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors |
| SK18942001A3 (sk) * | 1999-06-28 | 2002-10-08 | Janssen Pharmaceutica N. V. | Inhibítory replikácie respiračného syncytiálneho vírusu |
| UA74787C2 (en) * | 1999-06-28 | 2006-02-15 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors |
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| BRPI0417811A (pt) * | 2003-12-18 | 2007-03-27 | Tibotec Pharm Ltd | aminobenzimidazóis e benzimidazóis como inibidores da replicação do vìrus sincicial respiratório |
-
2004
- 2004-12-17 AR ARP040104755A patent/AR046959A1/es active IP Right Grant
- 2004-12-20 TW TW093139923A patent/TWI351401B/zh not_active IP Right Cessation
- 2004-12-20 CN CNA2004800378255A patent/CN1894237A/zh active Pending
- 2004-12-20 NZ NZ547479A patent/NZ547479A/en not_active IP Right Cessation
- 2004-12-20 EA EA200601178A patent/EA009876B1/ru unknown
- 2004-12-20 SI SI200430732T patent/SI1697345T1/sl unknown
- 2004-12-20 AT AT04817576T patent/ATE388950T1/de active
- 2004-12-20 PL PL04817576T patent/PL1697345T3/pl unknown
- 2004-12-20 MX MXPA06007112A patent/MXPA06007112A/es active IP Right Grant
- 2004-12-20 ME MEP-2008-207A patent/ME01042B/me unknown
- 2004-12-20 KR KR1020067014047A patent/KR100967406B1/ko active IP Right Grant
- 2004-12-20 PT PT04817576T patent/PT1697345E/pt unknown
- 2004-12-20 MY MYPI20045259A patent/MY143573A/en unknown
- 2004-12-20 DE DE602004012448T patent/DE602004012448T2/de active Active
- 2004-12-20 CA CA2548668A patent/CA2548668C/en active Active
- 2004-12-20 CN CN200810166056.9A patent/CN101412709B/zh active Active
- 2004-12-20 AU AU2004298460A patent/AU2004298460B2/en not_active Ceased
- 2004-12-20 UA UAA200606224A patent/UA84718C2/ru unknown
- 2004-12-20 AP AP2006003640A patent/AP2150A/xx active
- 2004-12-20 RS RSP-2008/0266A patent/RS50584B/sr unknown
- 2004-12-20 ES ES04817576T patent/ES2303653T3/es active Active
- 2004-12-20 WO PCT/EP2004/053620 patent/WO2005058871A1/en active Application Filing
- 2004-12-20 EP EP04817576A patent/EP1697345B1/en active Active
- 2004-12-20 BR BRPI0417268A patent/BRPI0417268B8/pt not_active IP Right Cessation
- 2004-12-20 DK DK04817576T patent/DK1697345T3/da active
- 2004-12-20 JP JP2006544467A patent/JP4951348B2/ja active Active
- 2004-12-20 US US10/563,691 patent/US7449463B2/en active Active
-
2006
- 2006-05-25 IL IL175910A patent/IL175910A/en active IP Right Grant
- 2006-06-14 EG EGNA2006000561 patent/EG25799A/xx active
- 2006-07-17 ZA ZA2006/05894A patent/ZA200605894B/en unknown
- 2006-07-18 NO NO20063322A patent/NO339314B1/no not_active IP Right Cessation
-
2008
- 2008-06-03 HR HR20080245T patent/HRP20080245T3/xx unknown
- 2008-06-12 CY CY20081100633T patent/CY1108142T1/el unknown
- 2008-06-17 US US12/140,686 patent/US8883837B2/en active Active
-
2009
- 2009-10-13 HK HK09109448.0A patent/HK1130799A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG25799A (en) | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | |
| TWI349007B (en) | Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | |
| ZA200605893B (en) | Aminobenzimidazones and benzimidazoles as inhibitors of respiratory syncytial virus replication | |
| IL177917A0 (en) | Macrocyclic compounds as inhibitors of viral replication | |
| EP1626717A4 (en) | BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS | |
| HK1166983A1 (zh) | 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途 | |
| IL172876A0 (en) | Substituted arylthiourea derivatives useful as inhibitors of viral replication | |
| IL222698A0 (en) | Benzazole derivatives, compositions, and methods of use as b- secretase inhibitors | |
| IL180488A0 (en) | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof of kinase inhibitors | |
| AP2006003808A0 (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
| IL192763A (en) | History of pyrimidine, preparations containing them and used in the preparation of cancer drugs | |
| ZA200608798B (en) | Macrocyclic compounds as inhibitors of viral replication | |
| IL182785A0 (en) | Particles for treatment of pulmonary infection | |
| ZA200609141B (en) | Compositions for Inhalation therapy and methods of use | |
| IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
| IL197783A (en) | Polycyclic compounds, preparations containing them and polycyclic compounds for use in the treatment of synthetic respiratory virus infections | |
| MY142783A (en) | 5-or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | |
| IL198634A0 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| SI1723136T1 (sl) | Piperidin-amino-benzimidazolni derivati kot inhibitorji replikacije respiratornega sincicijskega virusa | |
| IL176063A0 (en) | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | |
| EP2107904A4 (en) | COMPOSITIONS FOR THE REVERSAL AND DETOXIFICATION OF NARCOSIVE EQUIPMENT AND OTHER COMPOUNDS AND METHOD OF USE | |
| IL229418A0 (en) | Chemical derivatives of jesmont, pharmaceutical preparations and methods of using them | |
| IL191860A0 (en) | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof | |
| IL191861A0 (en) | Improved jasmonate derivatives, pharmaceutical compositions and methods of use thereof | |
| GB0500477D0 (en) | New Medical use of triazine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20221220 |